Quantitative Proteomics Reveals Neuroprotective Mechanism of Ginkgolide B in Aβ1-42-induced N2a Neuroblastoma Cells
Journal of Integrative Neuroscience · 2023
DOI: 10.31083/j.jin2202033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2023. Verfasst von Yidan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Hospital of Hebei Medical University, 050000 Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neuroblastoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Hebei Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Objective
Ginkgolide B (GB) possesses anti-inflammatory, antioxidant, and anti-apoptotic properties against neurotoxicity induced by amyloid beta (Aβ), but the potential neuroprotective effects of GB in Alzheimer’s therapies remain elusive. We aimed to conduct proteomic analysis of Aβ1-42 induced cell injury with GB pretreatment to uncover the underlying pharmacological mechanisms of GB.
Methods
Tandem mass tag (TMT) labeled liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was applied to analyze protein expression in Aβ1-42 induced mouse neuroblastoma N2a cells with or without GB pretreatment. Proteins with fold change >1.5 and p < 0.1 from two independent experiments were regarded as differentially expressed proteins (DEPs). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to analyze the functional annotation information of DEPs. Two key proteins osteopontin (SPP1) and ferritin heavy chain 1 (FTH1) were validated in another three samples using western blot and quantitative real-time PCR.
Results
We identified a total of 61 DEPs in GB treated N2a cells, including 42 upregulated and 19 downregulated proteins. Bioinformatic analysis showed that DEPs mainly participated in the regulation of cell death and ferroptosis by down-regulating SPP1 protein and up-regulating FTH1 protein.
Conclusions
Our findings demonstrate that GB treatment provides neuroprotective effects on Aβ1-42 induced cell injury, which may be related to the regulation of cell death and ferroptosis. The research puts forward new insights into the potential protein targets of GB in the treatment of Alzheimer’s disease (AD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Second Hospital of Hebei Medical University, 050000 Shijiazhuang, Hebei, China.
Förderung
- Scientific Research Project of Hebei Administration of Traditional Chinese Medicine
Zitieren
APA
Zhang, Y., Zhao, Y., Zhang, J., Gao, Y., Li, S., Chang, C., & Yang, G. (2023). Quantitative Proteomics Reveals Neuroprotective Mechanism of Ginkgolide B in Aβ1-42-induced N2a Neuroblastoma Cells. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2202033
Vancouver
Zhang Y, Zhao Y, Zhang J, Gao Y, Li S, Chang C, et al. Quantitative Proteomics Reveals Neuroprotective Mechanism of Ginkgolide B in Aβ1-42-induced N2a Neuroblastoma Cells. Journal of Integrative Neuroscience. 2023. doi:10.31083/j.jin2202033
BibTeX
@article{Zhang2023,
author = {Zhang, Yidan and Zhao, Yuan and Zhang, Jian and Gao, Ya and Li, Shuyue and Chang, Cui and Yang, Guofeng},
title = {Quantitative Proteomics Reveals Neuroprotective Mechanism of Ginkgolide B in Aβ1-42-induced N2a Neuroblastoma Cells},
journal = {Journal of Integrative Neuroscience},
year = {2023},
doi = {10.31083/j.jin2202033}
}
EUVIMED